NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE244094 Query DataSets for GSE244094
Status Public on Mar 13, 2024
Title Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris
Organism Candidozyma auris
Experiment type Expression profiling by high throughput sequencing
Summary Candida auris has emerged as a problematic fungal pathogen associated with high morbidity and mortality. Amphotericin B (AmB) is the most effective antifungal used to treat invasive fungal candidiasis, with resistance rarely observed among clinical isolates. However, C. auris possesses extraordinary resistant profiles against all available antifungal drugs, including AmB. In our pursuit of potential solutions, we conducted a screening of a panel of 727 FDA-approved drugs and identified the proton pump inhibitor lansoprazole (LNP) as a potent enhancer of AmB’s activity against C. auris. LNP also potentiates the antifungal activity of AmB against other medically important species of Candida and Cryptococcus. Our investigations into the mechanism of action unveiled that LNP metabolite(s) interact with a crucial target in the mitochondrial respiratory chain (complex III, known as cytochrome bc1). This interaction increases oxidative stress within fungal cells. Our results demonstrated the critical role of an active respiratory function in the antifungal activity of LNP. Most importantly, LNP restored the efficacy of AmB in an immunocompromised mouse model, resulting in a 1.7-log (~98%) CFU reduction in the burden of C. auris in the kidneys. Our findings strongly advocate for a thorough and comprehensive evaluation of LNP as a cytochrome bc1 inhibitor for combating drug-resistant C. auris infections.
 
Overall design Exponential C. auris AR0390 in RPMI 1640 medium were treated with DMSO (control), AmB (0.5 µg/ml), LNP (32 µg/ml), or the combination of AmB/LNP in triplicates for 3 hr at 35 °C.
 
Contributor(s) Salama EA, Elgammal Y, Wijeratne A, Lanman NA, Utturkar SM, Farhangian A, Lie J, Meunier B, Hazbun TR, Seleem MN
Citation(s) 38431850
Submission date Sep 26, 2023
Last update date Apr 11, 2024
Contact name Tony Hazbun
E-mail(s) [email protected]
Phone 7654968228
Organization name Purdue University
Department Borch Medicinal Chemistry and Molecular Pharmacology
Lab HANS 235
Street address 201 South University Street
City West Lafayette
State/province Indiana
ZIP/Postal code 47906
Country USA
 
Platforms (1)
GPL28368 Illumina NovaSeq 6000 ([Candida] auris)
Samples (12)
GSM7806557 DMSO sample 1 [A4]
GSM7806558 DMSO sample 2 [A5]
GSM7806559 DMSO sample 3 [A6]
Relations
BioProject PRJNA1021218

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE244094_raw_counts.xlsx 1.5 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap